EICHOR
● Recruiting
Validation of a Method of Screening for Sleep Disorders in Children With Cerebral Palsy, Using Connected Tools
Condition: Sleep Disorders · Sponsor: University Hospital, Brest
About this study
Cerebral palsy (CP) is the most common cause of child disability. Nearly 40% of PC children suffer from sleep disorders, which are not routinely screened. The neuro-cognitive, physical and environmental morbidity of sleep disorders should require their diagnosis and management. Limited access to the reference exam (polysomnography or PSG) delays the diagnosis and only allows screening of these disorders for a limited number of PC children. The hypothesis of our study is that connected technologies could optimize screening for sleep disorders in PC children by selecting children requiring PSG exploration and specific management.
This description comes directly from the study's public registry record.
Talk to the study team
Juliette Ropars, MD · 02 98 22 33 89 · juliette.ropars@chu-brest.fr
Always discuss trial participation with your own doctor first.
Locations (6)
| CHU Angers | Angers, France | Not Yet Recruiting |
| CHRU Brest | Brest, France | Recruiting |
| Fondation Ildys Ty-Yann | Brest, France | Not Yet Recruiting |
| ESEAN Nantes | Nantes, France | Not Yet Recruiting |
| AP-HP Hôpital Trousseau | Paris, France | Not Yet Recruiting |
| Kerpape | Ploemeur, France | Not Yet Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03915418